
The fava-bean derived PeptiStrong will be featured in an accessible drinkable yogurt format, highlighting the company’s AI platform that identifies bioactive peptides.
Associate Editor for Nutritional Outlook.

The fava-bean derived PeptiStrong will be featured in an accessible drinkable yogurt format, highlighting the company’s AI platform that identifies bioactive peptides.

Colostrum is gaining momentum in the market, with growth across multiple categories and increased distribution of this multifunctional ingredient.

In this interview, Aleix Sala-Vila, PhD, shares more on his recent project involving data from global cohorts on links between omega-3 biomarkers and incident dementia.

The FDA initiated an examination of the safety of the chemical preservative butylated hydroxyanisole (BHA) through a review of scientific information.

In this interview, Aleix Sala-Vila, PhD, explains the effect of diets on healthy aging, highlighting a study on supplementation with walnuts.

In this interview, Andrea Fuso, PhD, explains recent research the role of vitamin K in brain health, epigenetics, and its potential combination with S-adenosyl-L-methionine (SAMe).

The company is developing solutions for omega powders, berberine, CoQ10, vitamin C, and creatine powders, while also expanding R&D capabilities.

In this interview clip, Andrea Fuso, PhD, compares the effects of supplementation with S-adenosyl-L-methionine (SAMe) with supplementation of B vitamins.

In this interview, Aleix Sala-Vila, PhD, explains research on the effects of the Mediterranean diet on cardiovascular disease and cognitive decline.

Nutritional Outlook, in collaboration with market research firm SPINS, provides a deep dive into 2026's top trending ingredients in the nutraceutical space. This year's Ingredients to Watch focuses on ashwagandha, colostrum, creatine, and protein, with expert insights and detailed sales data.

In this interview, Aleix Sala-Vila, PhD, explains how research suggests ALA from foods like walnuts may support cardiovascular outcomes.

Expert insights on developing flavor trends driving consumer engagement.

In this interview, Aleix Sala-Vila shares his research that links higher omega-3 levels with reduced atherosclerosis, improved survival after cardiac events, and better heart failure outcomes.

The U.S. Food and Drug Administration will allow products made without petroleum-based synthetic dyes to carry the claim, and also approved two more natural color additives.

The new partnership aims to expand distribution across Europe, the Middle East, and Africa to support food innovation, plant-based development, and evolving consumer demands.

Congressman Nick Langworthy introduces the Dietary Supplement Regulatory Uniformity Act to reaffirm FDA oversight and end the "patchwork" of conflicting state laws.

The new Lacprodan BLG-100 Acidic whey protein aims to offer increased flexibility and accessibility in patient nutrition intake.

The new Probiotics Manufacturing Suite enables formulation with additional probiotic strains, new product concepts, and personalized wellness solutions.

Andrea Fuso, PhD, explains how B vitamins support brain energy metabolism, while SAMe drives neurotransmitter synthesis and methylation.

The Institute for the Advancement of Food and Nutrition Sciences (IAFNS) released nine principles to guide how foods are classified based on processing and formulation, aiming to improve consistency and transparency.

How do recent population and clinical studies link omega-3 blood levels—particularly DHA and EPA—to brain, cardiovascular, mental, reproductive, and exercise health, and what do these findings suggest about the value of biomarkers, disease risk reduction, and future research needs?

In this interview, Aleix Sala-Vila, PhD, explains results from a recently published longitudinal study linking omega-3 levels and risk of early-onset dementia.

In this interview, Andrea Fuso, PhD, explains how B vitamins influence methylation, antioxidant production, and SAMe synthesis through their role in one-carbon metabolism.

In this interview, Laura Allred, PhD, regulatory manager at the Gluten Free Certification Organization (GFCO), discusses ongoing concerns around gluten-free oat safety and explains why third-party certification remains critical regardless of potential regulatory changes.

In this interview, Laura Allred, PhD, of the Gluten Free Certification Organization explains why GFCO requires products to test below 10 ppm of gluten while maintaining support for the FDA’s 20 ppm regulatory threshold, highlighting analytical variability in testing methods.

In this interview, Laura Allred, PhD, regulatory manager at the Gluten Free Certification Organization (GFCO), discusses the U.S. Food and Drug Administration’s recent Request for Information on gluten labeling in packaged foods, highlighting key gaps in current regulations, including rye and barley labeling and oat safety.

In this interview, GC Rieber VivoMega discusses supply chain challenges, quality and regulatory standards, sustainability, and the growing role of algae-based omega-3s alongside traditional marine sources.

In this interview, Andrea Fuso, PhD, explains how one-carbon metabolism, through SAMe-driven DNA methylation, regulates gene expression and how declines in methylation capacity may influence aging and disease.

The in vitro study found that supplementation with Organic NatureKnit, a fruit- and vegetable-based fiber blend from FutureCeuticals, demonstrated sustained prebiotic effects compared with purified fibers.

The functional milk beverage Puleva Vita Calcio Colágeno combines functional milk and Collavant n2 to support joint health in a mainstream consumer product.